Utsumi T, Tsumura M, Yashiro M, Kato Z, Noma K, Sakura F
J Clin Immunol. 2024; 44(7):167.
PMID: 39073655
PMC: 11286708.
DOI: 10.1007/s10875-024-01758-x.
Fechner J, Lausen J
Adv Exp Med Biol. 2024; 1459:243-258.
PMID: 39017847
DOI: 10.1007/978-3-031-62731-6_11.
Shin B, Rothenberg E
Front Immunol. 2023; 14:1108368.
PMID: 36817475
PMC: 9928580.
DOI: 10.3389/fimmu.2023.1108368.
Ding J, Li Y, Larochelle A
Cells. 2023; 12(2).
PMID: 36672255
PMC: 9857267.
DOI: 10.3390/cells12020321.
Chen Q, Cevher M, Jiang Q, Wang S, Sun X, Roeder R
Proc Natl Acad Sci U S A. 2022; 119(42):e2213718119.
PMID: 36215477
PMC: 9586329.
DOI: 10.1073/pnas.2213718119.
Homodimeric and Heterodimeric Interactions among Vertebrate Basic Helix-Loop-Helix Transcription Factors.
Torres-Machorro A
Int J Mol Sci. 2021; 22(23).
PMID: 34884664
PMC: 8657788.
DOI: 10.3390/ijms222312855.
Mechanisms of Binding Specificity among bHLH Transcription Factors.
de Martin X, Sodaei R, Santpere G
Int J Mol Sci. 2021; 22(17).
PMID: 34502060
PMC: 8431614.
DOI: 10.3390/ijms22179150.
LMO2 is essential to maintain the ability of progenitors to differentiate into T-cell lineage in mice.
Hirano K, Hosokawa H, Koizumi M, Endo Y, Yahata T, Ando K
Elife. 2021; 10.
PMID: 34382935
PMC: 8360648.
DOI: 10.7554/eLife.68227.
Relationship between the structure and function of the transcriptional regulator E2A.
Liang J, Peng H, Wang J, Liu X, Ma L, Ni Y
J Biol Res (Thessalon). 2021; 28(1):15.
PMID: 34271975
PMC: 8283981.
DOI: 10.1186/s40709-021-00146-5.
A gain-of-function single nucleotide variant creates a new promoter which acts as an orientation-dependent enhancer-blocker.
Bozhilov Y, Downes D, Telenius J, Oudelaar A, Olivier E, Mountford J
Nat Commun. 2021; 12(1):3806.
PMID: 34155213
PMC: 8217497.
DOI: 10.1038/s41467-021-23980-6.
Clinical and Genetic Characterization of Craniosynostosis in Saudi Arabia.
Alghamdi M, Alhumsi T, Altweijri I, Alkhamis W, Barasain O, Cardona-Londono K
Front Pediatr. 2021; 9:582816.
PMID: 33937142
PMC: 8085561.
DOI: 10.3389/fped.2021.582816.
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds.
Canning P, Bataille C, Bery N, Milhas S, Hayes A, Raynaud F
J Immunol Methods. 2021; 494:113051.
PMID: 33794223
PMC: 8208243.
DOI: 10.1016/j.jim.2021.113051.
The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.
Meyer A, Herkt S, Kunze-Schumacher H, Kohrs N, Ringleb J, Schneider L
Sci Rep. 2020; 10(1):21438.
PMID: 33293632
PMC: 7722897.
DOI: 10.1038/s41598-020-78629-z.
Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2.
Milton-Harris L, Jeeves M, Walker S, Ward S, Mancini E
Oncotarget. 2020; 11(19):1737-1748.
PMID: 32477463
PMC: 7233811.
DOI: 10.18632/oncotarget.27580.
The histone H3K4 demethylase JARID1A directly interacts with haematopoietic transcription factor GATA1 in erythroid cells through its second PHD domain.
Karia D, Gilbert R, Biasutto A, Porcher C, Mancini E
R Soc Open Sci. 2020; 7(1):191048.
PMID: 32218938
PMC: 7029945.
DOI: 10.1098/rsos.191048.
ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L, Tan T, Durbin A, Zimmerman M, Abraham B, Tan S
Nat Commun. 2019; 10(1):5622.
PMID: 31819055
PMC: 6901540.
DOI: 10.1038/s41467-019-13515-5.
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization.
Wojnarowicz P, Lima E Silva R, Ohnaka M, Lee S, Chin Y, Kulukian A
Cell Rep. 2019; 29(1):62-75.e7.
PMID: 31577956
PMC: 6896334.
DOI: 10.1016/j.celrep.2019.08.073.
Transcriptional control of blood cell emergence.
Menegatti S, de Kruijf M, Garcia-Alegria E, Lacaud G, Kouskoff V
FEBS Lett. 2019; 593(23):3304-3315.
PMID: 31432499
PMC: 6916194.
DOI: 10.1002/1873-3468.13585.
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
Morishima T, Krahl A, Nasri M, Xu Y, Aghaallaei N, Findik B
Blood. 2019; 134(14):1159-1175.
PMID: 31366618
PMC: 6888148.
DOI: 10.1182/blood.2019000095.
Recurrent mutations in ALK-negative anaplastic large cell lymphoma.
Luchtel R, Zimmermann M, Hu G, Dasari S, Jiang M, Oishi N
Blood. 2019; 133(26):2776-2789.
PMID: 31101622
PMC: 6598380.
DOI: 10.1182/blood.2019000626.